What is changing?
The funded brand of capecitabine will change from Xeloda to Capecitabine Winthrop.
When will the change take effect?
- From 1 July 2014 Capecitabine Winthrop will be fully subsidised.
- From 1 September 2014 Xeloda will be reference priced. Capecitabine Winthrop will remain fully subsidised.
- From 1 December 2014, only the Capecitabine Winthrop brand of capecitabine will be subsidised. Xeloda will be delisted.
Capecitabine: 150mg and 500mg tablets
Change from Xeloda to Capecitabine Winthrop
You take capecitabine tablets, which play an important role in your cancer therapy. The brand of capecitabine that you currently take is called Xeloda.
PHARMAC recently made a decision to change the funded brand of capecitabine. This means that the brand you take will be changing from Xeloda to Capecitabine Winthrop.
The following information may help answer some questions you may have about this change.
Will the medicine work the same?
Your medicine itself is not changing, only the brand. The newly funded tablets contain the same amount of the active ingredient – capecitabine. This means that you should have the same effect from taking Capecitabine Winthrop as you currently do taking Xeloda.
Medsafe, the agency that approves medicines for use in New Zealand, carefully considered the safety and effectiveness of Capecitabine Winthrop tablets before approving it.
You shouldn’t notice any difference in how you feel after taking Capecitabine Winthrop. If you do notice any major changes or side effects, please talk with your doctor about it.
Will the medicine or pack look different?
Because Capecitabine Winthrop is made by a different supplier, the pack and tablets will look slightly different to what you are used to. Your capecitabine tablets will still come in a blister pack. Capecitabine Winthrop will still have the same active medicine and will work just the same.
When will the change occur?
From 1 July 2014 Capecitabine Winthrop will be available fully subsidised.
From 1 September 2014 only Xeloda tablets will be reference priced. Capecitabine Winthrop will be fully subsidised.
From 1 December 2014 only Capecitabine Winthrop will be fully subsidised. Xeloda will be delisted.
Will the new brand cost me any extra?
Other than the usual patient co-payment, there will be no extra cost for you for Capecitabine Winthrop.
Where can I get more information?
If you would like more information please contact the PHARMAC helpline on 0800 66 00 50 (between 9 am and 5 pm weekdays). You can also e-mail firstname.lastname@example.org with your queries and/or comments.
Your specialist and pharmacist will also help guide you during the changeover period.
Last updated: 4 July 2016